Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
ICU acquired pneumonia due to pseudomonas aeruginosa with and without multidrug resistance Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Effect of acenitobacter baumanii positive pneumonia on morbidity and mortality of patients Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Factors associated with community-acquired pneumonia in-hospital mortality in Portugal Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Factors affecting short and long-term mortality after community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015